Global Antibiotic R&D Partnership (GARDP)

The South African Medical Research Council renews funding for GARDP’s work in neonatal sepsis We are very grateful to the South African Medical Research Council (SAMRC) for renewing its funding for GARDP’s clinical trial aimed at evaluating much-needed antibiotic combinations for babies with sepsis. The trial will be conducted at Tygerberg hospital in Cape Town and Chris Hani Baragwanath Hospital in Johannesburg, as well as in Kenya, and will be rolled out to other countries in 2025. “We greatly appreciate SAMRC's support in this vital work, which has the potential to provide significant insights for local clinical management and effective treatment of newborns with sepsis.” Carol Ruffell (she/her) head of DNDi GARDP Southern Africa Neonatal sepsis affects up to 3 million newborns annually, with 214,000 deaths from drug-resistant sepsis each year. Learn more here: https://lnkd.in/d9MU7t_v #AMR #NeonatalSepsis #Antibiotics

Join us for #WorldEnvironmentDay for an interesting webinar on the challenge of manufacturing and procuring #antibiotics responsibly.  You will hear different perspectives on how different actors involved in healthcare and life sciences are building environmental considerations into their efforts to procure, manufacture antibiotics, and ultimately provide appropriate antibiotic access.  📅5 June, 12-1pm BST                      🔗Free registration: https://lnkd.in/gZPyjZqW                                              @BSI_UK @ShionogiUS

We warmly welcome the publication of The Lancet Series on Sustainable Access to Effective Antibiotics.  This important series shines a light on the urgent global need for coordinated action to tackle antibiotic resistance and enhance access to life-saving medications. The ambitious goals it sets, for reducing mortality and the inappropriate use of antibiotics by 2030, underscore the scale of the challenge we face.     GARDP is playing its part. Our innovative public-private partnership is helping to accelerate the development of, and improve access to, new and effective antibiotics.  Read the series now: https://lnkd.in/gsFvc5hS #AMR #LancetSeries #AntibioticResistance #GlobalHealth

We recently had the honor of welcoming Laurent Muschel, Director of the Health Emergency Preparedness and Response Authority (HERA) at the European Commission, to the STI Clinic of GGD Amsterdam. This visit highlighted the substantial role of HERA, alongside European Union Member States - including The Netherlands and Germany, in addressing the global health threat of AMR. Together and thanks to their support, we can accelerate the development of much-needed new antibiotic treatments for serious bacterial infections for adults and newborns, and people with STIs, while also ensuring there is global access to them. #HERA #EU #AMR #AntimicrobialResistance #STI EU in Emergencies

From 2022 until 2024, the GARDP Travel Award has supported researchers from LMICs who work on R&D of new treatments for drug-resistant infections to attend in-person conferences and training courses. Three researchers have benefitted from this award: Ankur Sood, Indian Institute of Technology, Madras Engraced Richard K Omole, Osun State University, Nigeria Akshay Dhanokar, Central University Of Rajasthan, India Find out more: https://lnkd.in/ecnn-42V #RandD #DrugDiscovery #AMR #REVIVE

"AMR knows no borders. We will succeed together or we will fail together. What we really need to develop is a more robust and sustainable ecosystem approach that supports public health-driven drug development linked to equitable and appropriate access." Jennifer Cohn Listen to our Global Access Director, Jennifer Cohn at the Multi-stakeholder Hearing on Antimicrobial Resistance. #AMR #Multistakeholderhearing #UN #AntimicrobialResistance #Access

Reflecting on our recent AMR Symposium co-hosted with chariteberlin, we're immensely grateful for the participation of distinguished speakers and dedicated attendees. A special thanks to our insightful panelists who discussed the critical role of public-private partnerships in accelerating antibiotic R&D and access. Your engagement is crucial in shaping a sustainable response to AMR. Together, we're driving change and making an impact! #GlobalHealth #AntibioticResistance #AMR #AMRSymposium

How are digital biology and biotechnology being used to design bioinspired antimicrobial Peptides? Read our latest Antimicrobial Viewpoint by Octávio Franco to discover: https://lnkd.in/dv47sMmN #Biotechnology #AntimicrobialViewpoints #REVIVE #DigitalBiology

Eager to know more about the challenge of manufacturing and procuring antibiotics responsibly? Join us on World Environment Day for an live webinar with Courtney Soulsby, Elisabete Dias Ramos, Gareth Morgan, Maneesh Paul. S., M. Sc., Ph.D., FIDSA., and Sam Gunasekar. 📆 5 June, 12:00 - 01:00pm BST Register now for free: https://lnkd.in/eHK5YcNc #Webinar #AMR #Manufacturing #Procurement #WorldEnvironmentDay

We are excited to share the launch of Federal Office of Public Health FOPH new #LoveLife campaign, a pivotal initiative targeting STIs that have been affected by antimicrobial resistance, including gonorrhoea. This campaign represents a critical step in public health awareness and education. #AMR #gonorrhoea #PublicHealth